Dhiraj Kumar Selected Research

2- (3- benzyl- 4- oxo- 3,4,5,6,7,8- hexahydrobenzo(4,5)thieno(2,3- d)pyrimidin- 2- ylsulfanylmethyl)- oxazole- 4- carboxylic acid (2-pyrrolidin-1-yl-ethyl)amide

10/2016

Facile synthesis of autophagonizer and evaluation of its activity to induce autophagic cell death in apoptosis-defective cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dhiraj Kumar Research Topics

Disease

27	Neoplasms (Cancer) 03/2022 - 09/2011
11	Infections 02/2022 - 09/2011
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 01/2016
8	Breast Neoplasms (Breast Cancer) 03/2022 - 08/2014
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Tuberculosis (Tuberculoses) 01/2021 - 11/2011
6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2015
5	Visceral Leishmaniasis (Kala Azar) 11/2013 - 08/2006
3	Nervous System Diseases (Neurological Disorders) 01/2022 - 11/2014
3	Melanoma (Melanoma, Malignant) 01/2017 - 01/2013
2	COVID-19 02/2022 - 01/2021
2	Multiple Sclerosis 01/2020 - 01/2016
2	Huntington Disease (Huntington's Disease) 01/2020 - 01/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2016
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
2	Hypoxia (Hypoxemia) 01/2018 - 08/2014
2	Insulin Resistance 01/2017 - 01/2015
2	Body Weight (Weight, Body) 01/2016 - 08/2014
2	Channelopathies 01/2016 - 11/2014
2	Leishmaniasis 03/2010 - 08/2006
1	Hemorrhage 02/2022
1	Thromboembolism 02/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Disease Progression 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 11/2021
1	Heart Failure 10/2021
1	Iron Deficiencies 10/2021
1	Cardiomyopathies (Cardiomyopathy) 10/2021
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2011
6	Peptides (Polypeptides)IBA 12/2020 - 03/2015
5	Pharmaceutical PreparationsIBA 10/2022 - 09/2016
5	CytokinesIBA 01/2020 - 09/2011
4	OsteopontinIBA 01/2021 - 09/2011
4	AntimonyIBA 11/2013 - 08/2006
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 09/2011
3	ChemokinesIBA 01/2021 - 01/2013
3	Biological ProductsIBA 12/2019 - 03/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2015
3	GoldIBA 01/2018 - 09/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 09/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 01/2014
3	SodiumIBA 11/2014 - 07/2010
2	LipidsIBA 01/2022 - 04/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2018
2	IronIBA 10/2021 - 12/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 11/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2016
2	CholesterolIBA 11/2018 - 04/2017
2	AntibodiesIBA 01/2018 - 08/2014
2	B7-H1 AntigenIBA 01/2018 - 01/2017
2	LuteolinIBA 01/2018 - 09/2015
2	Immune Checkpoint ProteinsIBA 01/2018 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 08/2014
2	ProteomeIBA 07/2016 - 07/2012
2	Ion Channels (Ion Channel)IBA 01/2016 - 11/2014
2	gluconic acid (gluconate)FDA LinkGeneric 11/2013 - 07/2010
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	Conditioned Culture MediaIBA 03/2022
1	RivaroxabanIBA 02/2022
1	AnticoagulantsIBA 02/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	SilverIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	enzalutamideIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Inhibitor of Apoptosis ProteinsIBA 01/2022
1	Adhesives (Glues)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	NeuregulinsIBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	Antimicrobial PeptidesIBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	Dental Implants (Dental Implant)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	proto-oncogene proteins pimIBA 11/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2021
1	ferric carboxymaltoseIBA 10/2021
1	Ferritins (Ferritin)IBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	durvalumabIBA 01/2021
1	InterferonsIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	bafilomycin A1IBA 01/2021
1	enhanced green fluorescent proteinIBA 01/2021

Therapy/Procedure

25	Therapeutics 02/2022 - 09/2011
3	Immunotherapy 01/2022 - 05/2017
3	Radiotherapy 01/2018 - 12/2016
3	Drug Therapy (Chemotherapy) 01/2017 - 09/2011
2	Duration of Therapy 03/2016 - 03/2010
1	Castration 01/2022